Clinical Trial

Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy

Study acronym: BRCA HRT Pilot
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to develop an educational aid about hormone replacement therapy that physicians can share with patients as part of their pre-surgical counseling for a risk-reducing salpingo-oophorectomy (RRSO).
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07-01 -> 2026-12-31 2026-08-05
minor Completion pushed: 2026-12-31 -> 2027-06-30 2026-08-05
Trial Details
NCT Number NCT06972719
Lead Sponsor Duke University
Conditions BRCA1 Mutation, BRCA2 Mutation
Enrollment 50 participants
Start Date 2025-09-30
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-04